Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06098586
Other study ID # 2023-04885-01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 15, 2023
Est. completion date November 15, 2027

Study information

Verified date October 2023
Source Karolinska Institutet
Contact Elin Swärd
Phone +4612360000
Email elin.sward@regionstockholm.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized controlled trial comparing partial wrist denervation to a self-managed exercise therapy program in 140 patients with wrist osteoarthritis.


Description:

Backgroud: High quality evidence regarding the effectiveness of non-operative and operative treatments in wrist osteoarthritis are lacking. Aim: To analyze: 1. Does partial wrist denervation and self-managed exercise therapy improve patient-reported outcomes, pain, grip strength and range of motion (ROM) in wrist OA? 2. Is any of the two treatment concepts partial wrist denervation and self-managed exercise therapy more efficient than the other in terms of patient-reported outcomes, pain relief, grip strength and range of motion? Method: A multicenter parallel group, two-arm, randomized, controlled, assessor blinded, trial of 140 patients. The study is conducted at the departments of hand surgery at Södersjukhuset Stockholm and Malmö University hospital. Group1: Self-managed exercise therapy program containing: - Patient education: - Exercise therapy program: The exercise therapy program is designed by Sara Larsson (physiotherapist at the Department of hand surgery in Malmö, Sweden), influenced by previous studies on wrist stability and proprioception. Focus is on functional re-learning and strengthening of the musculoskeletal system with the aim to create a stable wrist that can be used in a pain-free manner in activities of daily living. The program consists of neuromuscular exercises that focus on coordination, wrist stability and strength. Group 2: Surgery will be performed under local anesthesia (+ blood-less field or wide-awake local anesthesia no torniquet (WALANT) according to the surgeon's preference) through a single dorsal incision. AIN and PIN neurectomy will be performed as described by Berger (Berger, 1998). Primary outcome: Patient Rated Wrist Evaluation (PRWE) score (0-100) (MacDermid et al., 1998) 12 months after intervention.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 140
Est. completion date November 15, 2027
Est. primary completion date November 15, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years. - Chronic wrist pain (=6 months) due to Scapholunate advanced collapse (SLAC) / Scaphoid non-union advanced collapse (SNAC) grade 1-3 osteoarthritis. - Radiological signs of osteoarthritis on posteroanterior and lateral radiograph. Exclusion Criteria: - Previous PIN or AIN neurectomy. - Rheumatoid arthritis or other chronic inflammatory arthritis. - Symptomatic osteoarthritis in the distal radio-ulnar (DRU), Scapho-trapezio-trapezoid (STT) or thumb carpometacarpal (CMC) joints. - Ongoing infection. - Inability to co-operate with the follow-up protocol. - Systemic or intra-articular glucocorticoids or intraarticular PRP or Hyaluronic acid injections in the affected joint within 3 months prior to enrollment.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Self-managed exercise therapy program
Exercise program focusing on functional re-learning and strengthening of the musculoskeletal system with the aim to create a stable wrist that can be used in a pain-free manner in activities of daily living.
Procedure:
Partial wrist denervation
AIN and PIN neurectomy through a dorsal approach as described by Berger (Berger, 1998).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Outcome

Type Measure Description Time frame Safety issue
Primary PRWE Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998) 12 months
Secondary PRWE Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998) 3 months
Secondary PRWE Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998) 6 months
Secondary PRWE Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998) 5 years
Secondary Pain NRS Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004) 3 months
Secondary Pain NRS Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004) 6 months
Secondary Pain NRS Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004) 12 months
Secondary Pain NRS Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004) 5 years
Secondary EQ5D EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996) 3 months
Secondary EQ5D EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996) 6 months
Secondary EQ5D EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996) 12 months
Secondary EQ5D EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996) 5 years
Secondary GROC Global rating of change (GROC, -5-+5, higher score better outcome) 3 months
Secondary GROC Global rating of change (GROC, -5-+5, higher score better outcome) 6 months
Secondary GROC Global rating of change (GROC, -5-+5, higher score better outcome) 12 months
Secondary GROC Global rating of change (GROC, -5-+5, higher score better outcome) 5 years
Secondary Pain catastrophizing PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995) 3 months
Secondary Pain catastrophizing PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995) 6 months
Secondary Pain catastrophizing PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995) 12 months
Secondary Pain catastrophizing PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995) 5 years
Secondary ROM Range of motion (ROM) of the wrist. 3 months
Secondary ROM Range of motion (ROM) of the wrist. 6 months
Secondary ROM Range of motion (ROM) of the wrist. 12 months
Secondary ROM Range of motion (ROM) of the wrist. 5 years
Secondary Grip Grip strength (Jamar). 3 months
Secondary Grip Grip strength (Jamar). 6 months
Secondary Grip Grip strength (Jamar). 12 months
Secondary Grip Grip strength (Jamar). 5 years
Secondary Complications Complications related to treatment 3 months
Secondary Complications Complications related to treatment 6 months
Secondary Complications Complications related to treatment 12 months
Secondary Complications Complications related to treatment 5 years
Secondary Radiology Radiological grade of osteoarthritis 5 years after inclusion compared to baseline. 5 years
Secondary Cost Differences in direct costs associated with treatment and indirect costs. 12 months
Secondary sick leave length of sick leave 12 months
Secondary work ability to return to previous work 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04074863 - Norwegian Distal Ulna Resection - Replacement Study N/A
Recruiting NCT05367817 - Effects of a Neuromuscular Exercise Therapy Program for Treatment of Wrist Osteoarthritis: a Randomized Controlled Trial N/A
Completed NCT04235972 - Evaluation of Staple Watson Wrist Arthrodesis N/A